News
-
-
COMMUNIQUÉ DE PRESSE
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
Redcare Pharmacy N.V. reports a successful 2024 with strong growth, especially in Germany. Forecast for 2025 includes margin uplift and doubling of Rx sales, positioning the company as a market leader in multiple countries -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4.
Redcare Pharmacy N.V. reports impressive 32% sales growth in 2024, reaching EUR 2.4bn, with Germany's Rx sales soaring 142% in Q4. Active customer base grows to 12.5M -
-
